{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:52Z","timestamp":1786119412490,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/wnf.0b013e3181bbf3a7","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T01:51:27Z","timestamp":1267062687000},"page":"52-54","source":"Crossref","is-referenced-by-count":21,"title":["Hepatotoxicity After High-Dose Methylprednisolone for Demyelinating Disease"],"prefix":"10.1097","volume":"33","author":[{"given":"Anna","family":"Loraschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210203","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3748\/wjg.14.5474","article-title":"Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report.","volume":"14","author":"Takahashi","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R2-14-20210203","first-page":"314","article-title":"Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis.","volume":"25","author":"Das","year":"2006","journal-title":"Indian J Gastroenterol"},{"key":"R3-14-20210203","first-page":"356","article-title":"Autoimmune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS.","volume":"2","author":"Reu","year":"2007","journal-title":"CEJMed"},{"key":"R4-14-20210203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejim.2004.10.018","article-title":"Acute hepatitis related to prednisolone.","volume":"16","author":"Hofstee","year":"2005","journal-title":"Eur J Intern Med"},{"key":"R5-14-20210203","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/thy.2006.0267","article-title":"Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy.","volume":"17","author":"Le Moli","year":"2007","journal-title":"Thyroid"},{"key":"R6-14-20210203","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1345\/aph.1H171","article-title":"Methylprednisolone-induced toxic hepatitis.","volume":"40","author":"Topal","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R7-14-20210203","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/10428190500521101","article-title":"Non-alcoholic steatohepatitis occurring in a patient with T-lymphoblastic lymphoma during chemotherapy including prednisolone.","volume":"47","author":"Shigematsu","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"R8-14-20210203","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in drug-induced liver disease.","volume":"62","author":"Ramachandran","year":"2009","journal-title":"J Clin Pathol"},{"key":"R9-14-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R10-14-20210203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/03009748409100387","article-title":"Hepatotoxic effects of anti-rheumatic drugs in cultured rat hepatocytes.","volume":"13","author":"Akesson","year":"1984","journal-title":"Scand J Rheumatol"},{"key":"R11-14-20210203","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3727\/000000006783981530","article-title":"The effects of immunosuppressive agents on the function of human hepatocytes in vitro.","volume":"15","author":"Serrano","year":"2006","journal-title":"Cell Transplant"},{"key":"R12-14-20210203","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15287398209530176","article-title":"Effects of phospholipase A2 inhibitors on diethyl maleate-induced lipid peroxidation and cellular injury in isolated rat hepatocytes.","volume":"9","author":"Stacey","year":"1982","journal-title":"J Toxicol Environ Health"},{"key":"R13-14-20210203","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/1615-9861(200211)2:11<1577::AID-PROT1577>3.0.CO;2-G","article-title":"Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley rat.","volume":"2","author":"Man","year":"2002","journal-title":"Proteomics"},{"key":"R14-14-20210203","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0041-008X(92)90323-K","article-title":"Effect of pregnenolone-16 alpha-carbonitrile and dexamethasone on acetaminophen-induced hepatotoxicity in mice.","volume":"115","author":"Madhu","year":"1992","journal-title":"Toxicol Appl Pharmacol"},{"key":"R15-14-20210203","first-page":"2895","article-title":"Dexamethasone increases hepatotoxicity of MTX in children with brain tumors.","volume":"18","author":"Wolff","year":"1998","journal-title":"Anticancer Res"},{"key":"R16-14-20210203","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.transproceed.2008.01.077","article-title":"Effects of immunosuppressants on hepatocyte cell mitosis during liver regeneration in growing animal models of partial hepatectomy.","volume":"40","author":"Tannuri","year":"2008","journal-title":"Transplant Proc"},{"key":"R17-14-20210203","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1386-6346(00)00081-4","article-title":"Effect of methylprednisolone on the kinetics of cytokines and liver function of regenerating liver in rats.","volume":"19","author":"Fujioka","year":"2001","journal-title":"Hepatol Res"},{"key":"R18-14-20210203","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/0091270006287588","article-title":"Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A53 allele or a change in diet composition.","volume":"46","author":"Lee","year":"2006","journal-title":"J Clin Pharmacol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-201001000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:11:03Z","timestamp":1786039863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201001000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181bbf3a7","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}